Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Mar 24 S-8 POS Registration of securities for employees (post-effective amendment)
-
12 Oct 23 S-8 POS Registration of securities for employees (post-effective amendment)
Ambrx Biopharma similar filings
- 8 Mar 24 Registration of securities for employees (post-effective amendment)
- 8 Mar 24 Registration of securities for employees (post-effective amendment)
- 8 Mar 24 Registration of securities for employees (post-effective amendment)
- 12 Oct 23 Registration of securities for employees (post-effective amendment)
- 12 Oct 23 Registration of securities for employees (post-effective amendment)
- 12 Oct 23 Registration of securities for employees (post-effective amendment)
- 12 Oct 23 Registration of securities for employees (post-effective amendment)
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Post-Effective Amendment No. 1 to Registration Statement No. 333-271966 on Form S-8 of our report dated March 30, 2023, relating to the financial statements of Ambrx Biopharma Inc., appearing in the Annual Report on Form 10-K of Ambrx Biopharma Inc. for the year ended December 31, 2022.
/s/ Deloitte & Touche LLP
San Diego, California
October 12, 2023